LB Pharmaceuticals Inc
LBRX
$23.91
$0.331.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2,110.75% | 0.00% | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 245.68% | 0.00% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 2,040.59% | 0.00% | -- | ||
|
|
|||||
| Total Current Assets | 2,040.59% | 0.00% | -- | ||
| Net Property, Plant & Equipment | -3.18% | 0.00% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 0.79% | 0.00% | -- | ||
| Total Assets | 1,566.39% | 0.00% | -- | ||
|
|
|||||
| Total Accounts Payable | 307.87% | 0.00% | -- | ||
| Total Accrued Expenses | 30.93% | 0.00% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 0.00% | 0.00% | -- | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | 70.17% | 0.00% | -- | ||
|
|
|||||
| Total Current Liabilities | 70.17% | 0.00% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -3.13% | 0.00% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -51.06% | 0.00% | -- | ||
| Total Liabilities | 18.77% | 0.00% | -- | ||
|
|
|||||
| Common Stock & APIC | 3,930.58% | 0.00% | -- | ||
| Retained Earnings | -3.11% | 0.00% | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 398.65% | 0.00% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 0.00% | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 0.00% | -- | ||
|
|
|||||
| Total Common Equity | 398.65% | 0.00% | -- | ||
| Total Preferred Equity | -- | 0.00% | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 2,886.92% | 0.00% | -- | ||
|
|
|||||